Package Leaflet: Information for the Patient
Xilapro 8 mg Hard Capsules EFG
Silodosin
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet:
What is silodosin
Silodosin belongs to a group of medications called alpha-adrenergic receptor blockers.
Silodosin is selective for receptors located in the prostate, bladder, and urethra. By blocking these receptors, it causes relaxation of the smooth muscle of these tissues. This makes it easier for you to urinate and alleviates your symptoms.
What silodosin is used for
Silodosin is used in adult men to treat urinary symptoms associated with benign prostatic hyperplasia (BPH), such as:
Do not take silodosin
if you are allergic to silodosin or any of the other components of this medication (listed in section 6).
Warnings and Precautions
Consult your doctor or pharmacist before starting to take this medication:
When taking silodosin, dizziness and, occasionally, fainting may occur when standing up, especially when starting treatment or when taking other medications that lower blood pressure. If this happens, sit or lie down immediately until the symptoms disappear and inform your doctor as soon as possible (see also the section "Driving and Using Machines").
If your kidney problems are moderate, your doctor will start treatment with silodosin with caution and possibly with a lower dose (see section 3 "How to Take Xilapro"). If your kidney problems are severe, you should not take this medication.
Children and Adolescents
Do not give this medication to children and adolescents under 18 years of age, as there are no relevant indications for this age group.
Taking silodosin with other medications
Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
Inform your doctor in particular if you are taking:
Pregnancy and Breastfeeding
Silodosin is not indicated for use in women.
Fertility
Silodosin may reduce the amount of semen and temporarily affect your ability to conceive a child. If you intend to have a child, consult your doctor or pharmacist before using this medication.
Driving and Using Machines
Do not drive or operate machines if you feel faint, dizzy, or sleepy, or
have blurred vision.
Xilapro contains Sodium
This medication contains less than 23 mg of sodium (1 mmol) per hard capsule; it is essentially "sodium-free".
Follow the instructions for administration of this medication exactly as indicated by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
The recommended dose is one 8 mg silodosin capsule per day, administered orally.
Take the capsule always with food, preferably at the same time each day. Do not break or chew the capsule; swallow it whole, preferably with a glass of water.
Patient with Kidney Problems
If you have moderate kidney problems, your doctor may prescribe a different dose. For this purpose, the 4 mg silodosin hard capsule presentation is available.
If you take more silodosin than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested. If you feel dizzy or weak, inform your doctor immediately.
If you forget to take silodosin
You can take the capsule later the same day if you forget to take it before. If it is almost time for the next dose, do not take the missed dose. Do not take a double dose to make up for the missed capsule.
If you stop taking silodosin
If you stop treatment, it is possible that the symptoms will reappear.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Contact your doctor immediately if you experience any of the following allergic reactions, as their consequences could be serious: swelling of the face or throat, difficulty breathing, feeling of fainting, itching of the skin, or hives.
The most common side effect is a reduction in the amount of semen expelled during sexual intercourse. This effect disappears after discontinuation of treatment with silodosin. Inform your doctor if you are planning to have children.
Dizzinessmay occur, including dizziness when standing up, and, occasionally, fainting.
If you feel weak or dizzy, sit or lie down immediately until the symptoms disappear. If you experience dizziness when standing up or fainting, inform your doctor as soon as possible.
Silodosin may cause complications during cataract surgery(eye surgery for cataracts; see section "Warnings and Precautions").
It is essential that you inform your ophthalmologist immediately if you are using or have previously used silodosin.
The possible side effects are listed below:
Very Common Side Effects (may affect more than 1 in 10 people)
Common Side Effects (may affect up to 1 in 10 people)
Uncommon Side Effects (may affect up to 1 in 100 people)
Rare Side Effects (may affect up to 1 in 1,000 people)
Very Rare Side Effects (may affect up to 1 in 10,000 people)
Frequency Not Known (frequency cannot be estimated from available data)
Inform your doctor if you notice that your sexual intercourse is affected.
Reporting Side Effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medicines Agency's website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date stated on the carton and blister pack after "EXP". The expiration date is the last day of the month indicated.
PVC/PE/PVdC-Al blisters: Do not store above 30°C.
OPA/Alu/PVC-Aluminum blisters: This medication does not require special storage conditions.
Do not use this medication if you notice that it is damaged or shows signs of tampering.
Medications should not be disposed of via wastewater or household waste. Place the packaging and any unused medication in the SIGRE Collection Pointat your pharmacy. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
Xilapro Composition
Appearance of the Product and Package Contents
Xilapro 8 mg hard capsules: white, opaque, size 0, marked with an "8" in black ink.
Xilapro is available in packs of 30 capsules.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Adventia Pharma, S.L.
Calle Viera y Clavijo, 30, 2º
35002 Las Palmas de Gran Canaria (Spain)
Local Representative:
Atika Pharma, S.L.
Calle Viera y Clavijo, 30, 2º
35002 Las Palmas de Gran Canaria (Spain)
Manufacturer
TEVA Gyógyszergyár Zrt.
Pallagi út 13
Debrecen, 4042
Hungary
Date of Last Revision of this Package Leaflet: October 2023
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/